Regulatory T Cells in GVHD Therapy

Regulatory T Cells in GVHD Therapy

Graft versus host disease (GVHD) is a common complication and the leading cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Pharmacological immunosuppression used in GVHD prophylaxis and treatment lacks specificity and can increase the likelihood...

Full description

Bibliographic Details
Main Authors: Wen-wen Guo, Xiu-hua Su, Ming-yang Wang, Ming-zhe Han, Xiao-ming Feng, Er-lie Jiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Immunology
Subjects:
regulatory T cells
acute graft versus host disease
chronic graft versus host disease
hematopoietic stem cell transplantation
adoptive cellular therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.697854/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.697854/full

Similar Items